Aptevo Therapeutics (APVO) Misses Q3 EPS by 15c
Get Alerts APVO Hot Sheet
Join SI Premium – FREE
Aptevo Therapeutics (NASDAQ: APVO) reported Q3 EPS of ($1.50), $0.15 worse than the analyst estimate of ($1.35).
For earnings history and earnings-related data on Aptevo Therapeutics (APVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Employers Holdings (EIG) Misses Q1 EPS by 2c
- AptarGroup (ATR) Tops Q1 EPS by 11c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!